| Line Item | 2026-03-29 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $83.9M | — | -13.5% |
| Cost of Revenue | $62.0M | — | -18.0% |
| Gross Profit | $21.9M | — | +2.3% |
| R&D Expense | $1.4M | — | +27.3% |
| SG&A Expense | $11.4M | — | -9.5% |
| Operating Income | $6.2M | — | -18.4% |
| Pre-tax Income | $5.5M | — | -25.7% |
| Income Tax | $1.7M | — | -10.5% |
| Net Income | $3.6M | — | -34.5% |
| EPS (Basic) | $0.14 | — | -33.3% |
| EPS (Diluted) | $0.13 | — | -35.0% |
| Line Item | 2026-03-29 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $14.8M | +78.3% | +261.0% |
| Accounts Receivable | $59.3M | +33.0% | +15.4% |
| Inventory | $100.8M | +9.1% | +16.7% |
| Current Assets | $188.2M | +14.8% | +7.1% |
| Total Assets | $392.4M | +6.1% | +1.9% |
| Current Liabilities | $107.5M |
| Line Item | 2026-03-29 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$4.1M | — | -175.9% |
| Capital Expenditures | $2.0M | — | +66.7% |
| Investing Cash Flow | -$2.1M | — | -50.0% |
| Financing Cash Flow | $12.6M | — | +400.0% |
| Free Cash Flow | -$6.1M | — | -245.2% |
| +23.6% |
| Long-term Debt | $57.7M | +46.4% | +25.4% |
| Total Liabilities | $168.9M | +17.9% | +6.6% |
| Stockholders' Equity | $223.5M | -1.3% | -1.4% |